Mucous Membrane Decontamination Market Size & Share, by Drug Class (Antibiotics, Corticosteroids, Anti-Inflammatory Drug, Monoclonal Antibodies); Product Type (Alcohol, Non-Alcohol Based); Administration (Injectable, Oral, Topical); Distribution Channel (Drug Store, Online, Retail, Hospital Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4189
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Mucous Membrane Decontamination Market size is poised to cross USD 15 Billion by the end of 2035, growing at a CAGR of 15% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of mucous membrane decontamination was over USD 7 Billion. The growth of the market can be attributed to the higher prevalence of healthcare-associated infection in hospitals backed by the growing regulations of keeping hygiene in hospitals.  According to the data published by the National Library of Medicine, it was noticed that nearly ~1.7 million patients in hospital facilities get healthcare-associated infections (HCAIs) annually while around 98,000 of them die as a result of these infections, which is 1 in 17 patients across the globe.

The mucous membrane is the inner lining of particular organs that is often moist and found in the nose, stomach, mouth, and lungs. Mucous membrane decontamination is the procedure of decrement of the physiological flora along with pathogens. Furthermore, the global mucous membrane decontamination market is estimated to flourish on the back of a higher number of infections associated with wounds that require treatment to prevent severe symptoms where surgeries are mandated to treat the infectious wound. For instance, about 32% of surgical site infections were observed in patients in the year 2019. Additionally, the increasing inclination toward infection prevention and control is further projected to enlarge the market size over the forecast period. Hence, all these factors are expected to influence the growth of the market positively during the forecast period.

Get more information on this report: Request Free Sample PDF

Mucous Membrane Decontamination Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Number of Open Surgeries - In the United Kingdom, around 12 thousand coronary artery bypass surgeries were performed from 2019 to 2020.  While in 2020, the cases of post-open surgery complications were observed to grow by 2%.
  • Open surgeries involve cutting the skin to get a full view of the organs. It is a vital procedure where surgeons make incisions of around 10 inches using a scalpel to reach the infected part for repair. After experiencing open surgeries, a patient is observed to suffer from pulmonary embolism, hemorrhage, deep vein thrombosis, and wound infection. Hence, mucous membrane decontamination becomes useful, especially to treat wound infections. Hence, this factor is anticipated to influence the market growth positively over the forecast period.
  • Increasing Inclination of Global Population Toward Personal Hygiene - As of 2020, nearly 65% of people were observed to be utilizing basic hygiene services across the globe while nearly 2 billion people across the globe were observed to lack hygiene services such as washing hands with soaps. Such habits are projected to lead to severe skin infections.
  • Higher Prevalence of Post-Surgical Wound Infection - National Library of Medicine published a report showing that 310 million major surgeries are performed worldwide every year. Additionally, it was also noticed that around 4% of the patients get surgical site infection (SSIs). Therefore, the demand for mucous membrane decontamination emerges to treat SSIs.
  • Escalating Prevalence of Autoimmune Diseases - About 3 million people in the United Kingdom were observed to be suffering from at least one autoimmune disease. For instance, approximately 32% people in the USA suffer from obesity, nearly 20% of them have cardiovascular diseases, and type 2 diabetes mellitus has effected nearly 15% of the USA pollution.
  • Surge in the C-Section Deliveries - as of 2021, it was observed that in the United States, around 30% of the were c-sectioned while primary cesarean deliveries rate was projected to be around 20 per 100 births.


  • Lack of Awareness of the Skin and Autoimmune Diseases
  • People across the globe are not much aware of mucous membrane decontamination if it is not facilitated by the healthcare providers. It can be further responsible for bacteriostatic effect. Owing to such lack of awareness increases the chances of occurrence of various preventable infection in patients. Hence, this factor is projected to hamper the growth of the market over the forecast period.
  • Shortage of Required Medication
  • Higher Cost Associated with Mucous Membrane Decontamination

Mucous Membrane Decontamination Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

USD 7 Billion

Forecast Year Market Size (2035)

USD 15 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Mucous Membrane Decontamination Sensors Segmentation

The global mucous membrane decontamination market is segmented and analyzed for demand and supply by administration into injectable, oral and topical. Out of the three types of administration, the oral segment is estimated to gain the largest market share in the year 2035. The growth of the segment can be attributed to the convenience availability and medicines orally administered and suitable for treating various diseases to provide quick relief coupled with higher prescription by doctors. Data released by Frontiers in Pharmacology in 2021 demonstrated that nearly 84% of pharmaceutical products are consumed orally. Oral route of drug administration is common and had been practiced for centuries. It also provides tons of benefits such as, low complexity, non-invasiveness, convenient, easy to purchase, no need of prescription for several oral drugs, affordable, and others. 

The global mucous membrane decontamination market is also segmented and analyzed for demand and supply by drug class into antibiotics, corticosteroids, anti-inflammatory drug, and monoclonal antibodies. Amongst these four segments, the monoclonal antibodies segment is expected to garner a significant share in the year 2035. Monoclonal antibodies are the synthetic proteins prepared in the laboratories that are used on the cancer cells to bind them. Monoclonal antibodies are useful in carrying radioactive substances toxins, and drugs to cancer cells. Hence, there utilization is associated with cancer treatment. For instance, in 2020, around 10 million people lost their life.

Our in-depth analysis of the global mucous membrane decontamination market includes the following segments:

                By Drug Class

  • Antibiotics
  • Corticosteroids
  • Anti-Inflammatory Drug
  • Monoclonal Antibodies

               By Product Type

  • Alcohol Based
  • Non-Alcohol Based

               By Administration

  • Injectable, Oral
  • Topical

              By Distribution Channel

  • Drug Store
  • Online
  • Retail
  • Hospital Pharmacies

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Mucous Membrane Decontamination Industry - Regional Synopsis

North America Market Forecast

The North American mucous membrane decontamination market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the higher prevalence of autoimmune diseases backed by the presence of a developed healthcare infrastructure and the growing inclination of people and clinicians toward the utilization of novel drugs. For instance, in 2017, approximately 22 million Americans were anticipated to have at least one autoimmune disease. The number is further set to rise exponentially over the forecast period. Additionally, rapid growth in the health expenditure in the region which is expected to increase the spending capacity of people on health care is further anticipated to enlarge the market size over the forecast period. As of 2020, the national health expenditure of the United States was estimated to be around USD 4 trillion.

Asia Pacific Market Forecast

Furthermore, the market is also expected to witness notable growth opportunities in the Asia Pacific region with a total market share during the forecast period. rising prevalence of skin infection such as moles, eczema, warts and fungal infection is estimated to propel the market growth over the forecast period. For instance, nearly 85% of the people aged between 30 to 60 are projected to be living with HPV infection, out of which, nearly 75% of them are Chinese and around 2% of them are Indians.  Additionally, increasing prevalence or autoimmune disease coupled with rising instances of open surgeries in the region are also expected to boost the growth of the market over the forecast period.

Europe Market Forecast

Moreover, the mucous membrane decontamination market is projected to witness moderate growth opportunities in the Europe region by holding a share during the forecast period. Similar factors such as, escalating instances of skin infection and spike in the prevalence of autoimmune diseases are estimated to fuel the market growth during forecast period.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Mucous Membrane Decontamination Landscape

    • Astellas Pharma Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bausch Health Companies Inc.
    • Genentech, Inc.
    • Lipidor AB
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Sun Pharmaceutical Industries Limited
    • EPI Health, LLC
    • Mölnlycke Health Care AB
    • Reckitt Benckiser Group plc

In the News

  • Astellas Pharma Inc. announced its global strategic collaboration with Sutro Biopharma, Inc. along with licensing agreement to improvise the development procedure of novel immunostimulatory antibody-drug conjugates shortly known as iADCs.

  • Sun Pharmaceutical Industries Limited and its entirely owned subsidiaries launched an oral drug, Bempedoic Acid, under the brand name Brillo in India which focuses on low-density lipoprotein cholesterol to be decreased.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4189
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing inclination of global population toward personal hygiene and higher prevalence of post-surgical wound infection are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 15% over the forecast period, i.e., 2023-2035.

Lack of awareness of the skin and autoimmune diseases are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Bausch Health Companies Inc., Genentech, Inc., Lipidor AB, Pfizer Inc., Merck & Co., Inc., Sun Pharmaceutical Industries Limited, EPI Health, LLC, Mölnlycke Health Care AB, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by drug class, product type, administration, distribution channel, and by region.

The oral segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Mucous Membrane Decontamination Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying